---
title: 'Characteristics and outcomes in patients with a prior myocardial infarction
  treated with extended dual antiplatelet therapy with ticagrelor 60 mg: findings
  from ALETHEIA, a multi-country observational study'
date: '2023-08-31'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37653447/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230901181326&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: This study provides insights into the use of ticagrelor
  60 mg in patients with prior MI in clinical practice. Observed event rates for ischemic
  events and bleeding generally align with those in the pivotal trials, support the
  established safety profile of ticagrelor, and highlight the significant residual
  ischemic risk in this population.Clinical Trials.gov Registration ...'
disable_comments: true
---
CONCLUSIONS: This study provides insights into the use of ticagrelor 60 mg in patients with prior MI in clinical practice. Observed event rates for ischemic events and bleeding generally align with those in the pivotal trials, support the established safety profile of ticagrelor, and highlight the significant residual ischemic risk in this population.Clinical Trials.gov Registration ...